Paper9738985
Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes.
Yanase M and 5 others. Jpn J Cancer Res, 1998. Cited by 104 papers, by iCite.
Cite this record
ConductScience Library. Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Papers, record 9738985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9738985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glioma | Major topic |
| Hyperthermia, Induced | Major topic |
| Liposomes | Major topic |
| Magnetics | Major topic |
| Animals | |
| Female | |
| Rats | |
| Rats, Inbred F344 | |
| Tumor Cells, Cultured |
Source PubMed
References13
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7908891 | V delta 5+ T cells of BALB/c mice recognize the murine heat shock protein 60 target cell specificity. | Immunology | 1994 | https://conductscience.org/library/papers/7908891 | PubMed |
| 2 | 6724613 | Observations on the use of ferromagnetic implants for inducing hyperthermia. | IEEE Trans Biomed Eng | 1984 | https://conductscience.org/library/papers/6724613 | PubMed |
| 3 | 9242454 | Reduced efficacy of allogeneic versus syngeneic fibroblasts modified to secrete cytokines as a tumor vaccine adjuvant. | Cancer Res | 1997 | https://conductscience.org/library/papers/9242454 | PubMed |
| 4 | 8433026 | Inductive heating of ferrimagnetic particles and magnetic fluids: physical evaluation of their potential for hyperthermia. | Int J Hyperthermia | 1993 | https://conductscience.org/library/papers/8433026 | PubMed |
| 5 | 9310134 | Intracellular hyperthermia for cancer using magnetite cationic liposomes: ex vivo study. | Jpn J Cancer Res | 1997 | https://conductscience.org/library/papers/9310134 | PubMed |
| 6 | 8012282 | Interferon-beta endogenously produced by intratumoral injection of cationic liposome-encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain. | Biochem Mol Biol Int | 1994 | https://conductscience.org/library/papers/8012282 | PubMed |
| 7 | 3559297 | Interstitial microwave antennas for thermal therapy. | Int J Hyperthermia | 1987 | https://conductscience.org/library/papers/3559297 | PubMed |
| 8 | 9045948 | Intracellular hyperthermia for cancer using magnetite cationic liposomes: in vitro study. | Jpn J Cancer Res | 1996 | https://conductscience.org/library/papers/9045948 | PubMed |
| 9 | 7533813 | Development of intra-arterial hyperthermia using a dextran-magnetite complex. | Int J Hyperthermia | 1994 | https://conductscience.org/library/papers/7533813 | PubMed |
| 10 | 2582445 | Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling. | Cancer Res | 1989 | https://conductscience.org/library/papers/2582445 | PubMed |
| 11 | 9617354 | Intracellular hyperthermia for cancer using magnetite cationic liposomes: an in vivo study. | Jpn J Cancer Res | 1998 | https://conductscience.org/library/papers/9617354 | PubMed |
| 12 | 7963810 | Experimental study on thermal damage to dog normal brain. | Int J Hyperthermia | 1994 | https://conductscience.org/library/papers/7963810 | PubMed |
| 13 | 2370687 | Human T-cell leukemia virus type I trans activator induces class I major histocompatibility complex antigen expression in glial cells. | J Virol | 1990 | https://conductscience.org/library/papers/2370687 | PubMed |
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 104 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42643921 | Clinical Translation of Functional Magnetic Nanoparticles for Intracellular Hyperthermia and Cancer Immunotherapy. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42643921 | PubMed |
| 42559406 | Magnetic hyperthermia as an intracellular immunomodulatory technology: From heat transduction to tumor immune reprogramming. | Theranostics | 2026 | https://conductscience.org/library/papers/42559406 | PubMed |
| 41540320 | A novel murine model of LITT for glioblastoma reveals tumor reduction, BBB permeabilization, and drug delivery via ThermoDox®. | Drug Deliv Transl Res | 2026 | https://conductscience.org/library/papers/41540320 | PubMed |
| 41466973 | Heating up the immune battle: Magnetic hyperthermia against cancer. | Fundam Res | 2025 | https://conductscience.org/library/papers/41466973 | PubMed |
| 40822708 | Novel bioengineering strategies for drug delivery systems. | Appl Mater Today | 2023 | https://conductscience.org/library/papers/40822708 | PubMed |
| 39337552 | Magnetic Hyperthermia in Glioblastoma Multiforme Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337552 | PubMed |
| 37182180 | The emerging nanomedicine-based technology for non-small cell lung cancer immunotherapy: how far are we from an effective treatment. | Front Oncol | 2023 | https://conductscience.org/library/papers/37182180 | PubMed |
| 36672278 | Validation of a Temperature-Feedback Controlled Automated Magnetic Hyperthermia Therapy Device. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36672278 | PubMed |
| 36587223 | Engineering magnetic nano-manipulators for boosting cancer immunotherapy. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/36587223 | PubMed |
| 36428680 | Molecular Events in the Melanogenesis Cascade as Novel Melanoma-Targeted Small Molecules: Principle and Development. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36428680 | PubMed |
| 35844506 | Immunogenic Cell Death and Role of Nanomaterials Serving as Therapeutic Vaccine for Personalized Cancer Immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/35844506 | PubMed |
| 35742905 | Immunomodulation of Melanoma by Chemo-Thermo-Immunotherapy Using Conjugates of Melanogenesis Substrate NPrCAP and Magnetite Nanoparticles: A Review. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35742905 | PubMed |
| 35519777 | Structural control of magnetite nanoparticles for hyperthermia by modification with organic polymers: effect of molecular weight. | RSC Adv | 2020 | https://conductscience.org/library/papers/35519777 | PubMed |
| 35489652 | Laser ablation: Heating up the anti-tumor response in the intracranial compartment. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35489652 | PubMed |
| 35158809 | Combined Fluorescence-Guided Resection and Intracavitary Thermotherapy with Superparamagnetic Iron-Oxide Nanoparticles for Recurrent High-Grade Glioma: Case Series with Emphasis on Complication Management. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35158809 | PubMed |
| 34771448 | Magnetic Particle Imaging: An Emerging Modality with Prospects in Diagnosis, Targeting and Therapy of Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34771448 | PubMed |
| 34683540 | Magnetic Nanoparticles Used in Oncology. | Materials (Basel) | 2021 | https://conductscience.org/library/papers/34683540 | PubMed |
| 34307177 | Local Destruction of Tumors and Systemic Immune Effects. | Front Oncol | 2021 | https://conductscience.org/library/papers/34307177 | PubMed |
| 34073106 | Magnetic Nanostructures as Emerging Therapeutic Tools to Boost Anti-Tumour Immunity. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34073106 | PubMed |
| 33808973 | Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33808973 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9738985
GET https://conductscience.org/api/papers/v1/9738985/cited_by?page=2